Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-06-20
1988-05-31
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 86, A61K 31395, A61K 3140, C07D47104
Patent
active
047481790
ABSTRACT:
.beta.-carbolin-3-carboxylic acid derivatives of the general formula ##STR1## wherein R.sup.1 is methyl, ethyl, n-propyl or iso-propyl, and wherein
REFERENCES:
patent: 3202667 (1965-08-01), Szuszkovicz et al.
patent: 4371536 (1983-02-01), Braestrup et al.
patent: 4435403 (1984-03-01), Braestrup et al.
In re Schaumann et al, 197, USPO 5 (CCPA 1978).
L. H. Jensen et al., Bidirectional Effects of Benzodiazeping Receptor Ligands Against Picrotoxin etc., 183-191 (1983).
Braestrup Claus T.
Honore Tage
Jensen Leif H.
Petersen Erling
Seidelmann Dieter
Richter J.
Rotman Alan L.
Schering Aktiengesellschaft
LandOfFree
.beta.-carbolin-3-carboxylic acid derivatives and their use as b does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-carbolin-3-carboxylic acid derivatives and their use as b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-carbolin-3-carboxylic acid derivatives and their use as b will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1874524